TY  - JOUR

T1  - The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long‐term follow‐up results from <scp>BSBMT</scp>/<scp>UKMF</scp> Myeloma X Relapse [Intensive]): a randomised, open‐label, phase 3 trial

JO  - British Journal of Haematology

UR  - https://doi.org/10.1111/bjh.15782

PY  - 2019/02/06

AU  - Cook G

AU  - Royle K

AU  - O'Connor S

AU  - Cairns DA

AU  - Ashcroft AJ

AU  - Williams CD

AU  - Hockaday A

AU  - Cavenagh JD

AU  - Snowden JA

AU  - Ademokun D

AU  - Tholouli E et al

ED  - 

DO  - DOI: 10.1111/bjh.15782

PB  - Wiley

VL  - 185

IS  - 3

SP  - 450

EP  - 467

Y2  - 2025/11/15

ER  -